Tamara P. Miller
Emory University(US)Children's Healthcare of Atlanta(US)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Neutropenia and Cancer Infections, Acute Myeloid Leukemia Research, Pharmaceutical studies and practices
Most-Cited Works
- → Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children(2024)144 cited
- → Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events(2019)59 cited
- → Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia(2016)51 cited
- → Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age‐dependent: Report from Dana‐Farber Cancer Institute ALL Consortium Protocol 00‐01(2011)48 cited
- → The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia(2016)47 cited
- → Using electronic medical record data to report laboratory adverse events(2017)44 cited
- → Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials(2022)38 cited
- → Sec5, a member of the exocyst complex, mediates Drosophila embryo cellularization(2010)34 cited
- → Supportive Care in Pediatric Oncology: Opportunities and Future Directions(2023)24 cited
- → Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group(2022)23 cited